Bryce Point Capital LLC acquired a new position in Waters Co. (NYSE:WAT - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,415 shares of the medical instruments supplier's stock, valued at approximately $525,000.
A number of other institutional investors and hedge funds have also bought and sold shares of WAT. Bank of Jackson Hole Trust acquired a new position in shares of Waters during the fourth quarter valued at about $34,000. Fortitude Family Office LLC raised its holdings in Waters by 235.7% in the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after acquiring an additional 66 shares in the last quarter. Steward Partners Investment Advisory LLC lifted its position in shares of Waters by 129.3% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock worth $35,000 after acquiring an additional 53 shares during the period. Murphy & Mullick Capital Management Corp acquired a new stake in shares of Waters during the 4th quarter worth approximately $42,000. Finally, EverSource Wealth Advisors LLC lifted its position in Waters by 54.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier's stock worth $46,000 after purchasing an additional 44 shares during the period. Institutional investors own 94.01% of the company's stock.
Wall Street Analyst Weigh In
WAT has been the subject of a number of analyst reports. UBS Group raised their price objective on shares of Waters from $405.00 to $410.00 and gave the stock a "neutral" rating in a report on Thursday, February 13th. Robert W. Baird upgraded Waters from a "neutral" rating to an "outperform" rating and upped their price objective for the company from $396.00 to $407.00 in a research note on Wednesday, March 26th. KeyCorp upgraded Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 target price for the company in a research report on Monday, March 31st. Barclays upgraded Waters from an "underweight" rating to an "equal weight" rating and upped their price target for the company from $360.00 to $415.00 in a research report on Monday, February 10th. Finally, StockNews.com cut shares of Waters from a "buy" rating to a "hold" rating in a research report on Tuesday, February 25th. Ten analysts have rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, Waters presently has a consensus rating of "Moderate Buy" and a consensus target price of $401.31.
Check Out Our Latest Report on WAT
Waters Trading Up 9.2 %
Shares of Waters stock traded up $28.21 on Wednesday, reaching $335.92. 1,254,586 shares of the company's stock were exchanged, compared to its average volume of 472,796. The firm's 50-day moving average is $372.44 and its two-hundred day moving average is $372.68. The company has a market capitalization of $19.96 billion, a P/E ratio of 31.37, a price-to-earnings-growth ratio of 3.79 and a beta of 1.04. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94. Waters Co. has a 52 week low of $279.24 and a 52 week high of $423.56.
Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Sell-side analysts predict that Waters Co. will post 12.86 EPS for the current fiscal year.
About Waters
(
Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Further Reading
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
